4//SEC Filing
BLECH ISAAC 4
Accession 0001127602-18-025372
CIK 0001472091other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 8:01 AM ET
Size
5.3 KB
Accession
0001127602-18-025372
Insider Transaction Report
Form 4
BLECH ISAAC
Director
Transactions
- Award
Restricted Stock Units
2018-08-14+10,000→ 10,000 total→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- [F2]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- [F3]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0000905536
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 8:01 AM ET
- Size
- 5.3 KB